Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

SRRK

Scholar Rock

Cambridge, Massachusetts-based biopharmaceutical company, Scholar Rock Holding Corporation, is devoted to pioneering medicines for the treatment of severe diseases where the activation of protein g...

Scholar Rock Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

OKYO

OKYO Pharma Limited

London-based preclinical biopharmaceutical firm TOKYO Pharma Limited has made significant strides in the development of therapeutics targeted at managing and treating inflammatory eye diseases and ...

OKYO Pharma Limited Annual Report 2021

Healthcare Biotechnology LSE 1-10

IMAB

I-MAB

I-Mab Breaks Ground in Biopharmaceutical Industry Shanghai-based I-Mab, a clinical stage biopharmaceutical company, has been making waves in the field with its cutting-edge research in cancer and ...

I-MAB Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CBAY

CymaBay Therapeutics

Clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. is dedicated to the development of therapies for treating liver and chronic diseases. Its lead product candidate, seladelpar (MBX...

CymaBay Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

SVRA

Savara Pharmaceuticals

Austin-based Savara Inc., a clinical stage biopharmaceutical firm, is zeroing in on rare respiratory diseases with its innovative approach. The company's frontrunner is its star candidate, molgramo...

Savara Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

OPCH

Option Care Health

Option Care Health, Inc.: Your Partner for Home Health Care Services Option Care Health, Inc., headquartered in Bannockburn, Illinois, is a leading provider of home and alternate site infusion ser...

Option Care Health Annual Report 2023

Healthcare NASDAQ 1001-5000

CSBR

Champions Oncology

Champions Oncology, Inc. is leading the way in personalized cancer care with its innovative Tumorgraft Technology Platform. This platform involves implanting human tumors in immune-deficient mice a...

Champions Oncology Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

TLY

Totally Plc

Based in the UK, Totally Plc is a major player in the healthcare industry, catering to patients outside of traditional hospital settings. The company offers a variety of services aimed at enhancing...

Totally Plc Annual Report 2023

Healthcare LSE 51-200

EVLO

Evelo Biosciences, Inc.

Evelo Biosciences, a clinical-stage biotech firm headquartered in Cambridge, Massachusetts, is dedicated to developing oral medicines that have systemic effects by targeting immune cells in the sma...

Evelo Biosciences, Inc. Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

BLRX

BioLineRx Ltd.

Biopharmaceutical company BioLineRx Ltd. is making waves in the field of oncology with its cutting-edge drug development program. The company's lead candidate, Motixafortide, has completed Phase 3 ...

BioLineRx Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

PINC

Premier

Premier, Inc., a US-based healthcare improvement company, is making waves in the industry with its two segments, Supply Chain Services and Performance Services. The former provides members with an ...

Premier Annual Report 2023

Healthcare Healthcare Information Services NASDAQ 1001-5000

ICCC

ImmuCell

ImmuCell Corporation, a prominent animal health developer, manufacturer, and distributor based in Portland, Maine, has expanded its reach beyond the borders of the United States. Its products, whic...

ImmuCell Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

LJPC

La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company is a biopharmaceutical company that specializes in the development of life-saving medicines. Its main focus is on creating therapeutics to treat severe illnesses. Th...

La Jolla Pharmaceutical Company Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

IMUX

Immunic

Immunic, a clinical-stage biopharmaceutical company, is developing a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its most prom...

Immunic Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

EHE

Estia Health Ltd

Estia Health Limited is an Australian company that owns and manages residential aged care facilities. The company focuses on providing clinical care services, including nursing, pharmaceuticals adm...

Estia Health Ltd Annual Report 2023

Healthcare Long-Term Care Facilities ASX 5001-10,000